JPRN-UMIN000008360已完成未知
Blood pressure lowering effect of one compound tablet replacement as two tablets of angiotensin 2 receptor blocker(ARB) and calcium channel blocker(CCB) - ECO Tablet trial
Department of Cardiovascular Medicine, Okayama Univesity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 个研究点目标入组 200 人开始时间: 2012年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •a) patient with previous allergic reaction to azelnidipine or olmesartan. b) female patient who has possibility of pregnancy. c) patient treated with azole antifungal drug or HIV protease inhibitor. d) patient who has taken hemodialysis or has severe renal dysfunction (serume creatine level is above 2.0mg/dL). e) patient considered to be improper to this study by attending doctor.
研究者
相似试验
尚未招募
4 期
Blood pressure lowering effect of combination therapy of angiotensin receptor blocker (ARB) and Ca antagonist in patients with high risk hypertensioHypertensionJPRN-UMIN000002207Department of Cardiovascular Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School40
已完成
不适用
Medication induced blood pressure reduction; assessment of cerebral perfusion and cognition in hypertensive elderlyhypertensionhigh blood pressure1000796310057166NL-OMON33986niversitair Medisch Centrum Sint Radboud60
尚未招募
4 期
Combination low dose blood pressure lowering treatment for patients with untreated hypertensioHypertensionACTRN12617001533381George Medicines12
已完成
不适用
Comparison of blood pressure lowering effects of increasing dose of calcium channel blocker or adding diuretics in patients with insufficient blood pressure control with moderate dose of angiotensin receptor blocker and calcium channel blocker.HypertensionJPRN-UMIN000011328Toshio Kushiro170
已完成
不适用
Study of effect of blood pressure suppression by intake of MekabuHealthy AdultsJPRN-UMIN000046597Healthcare Systems Co., Ltd.60